# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-23-000009
Filing Date
2023-02-01
Accepted
2023-02-01 07:55:05
Documents
3
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | a230201-nisar_6k.htm | 6-K | 20720
2 |  | a230201-99_1.pdf | EX-99 | 4416646
3 |  | a230201-99_2.pdf | EX-99 | 6686080
| Complete submission text file | 0001370368-23-000009.txt |  | 15314671

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 23574769
SIC: 2834 Pharmaceutical Preparations